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Growth is a fundamental aspect of life cycle of all organisms. Body size varies 
highly in most animal groups, such as mammals. Moreover, growth of a 
multicellular organism is not uniform enlargement of size, but different body 
parts and organs grow to their characteristic sizes at different times. Currently 
very little is known about the molecular mechanisms governing this organ-
specific growth.  
Regulation of gene expression provides a potential, but currently unexplored, 
means of size control. This thesis presents novel methods and data about 
determination of DNA-binding specificities of important growth-related 
transcription factors, and prediction of human and mouse enhancer elements 
in genome-wide scale. We found multiple tissue-specific enhancers in critical 
growth regulatory genes thereby uncovering a potential mechanism for organ-
specific growth control and tumor-type specificity of oncogenes. Furthermore, 
a variation in a single nucleotide, which carries a susceptibility to colorectal 
cancer, was located to an enhancer element. The results implicate a mechanistic 
explanation on how this single-nucleotide polymorphism might be involved in 
generation of colorectal cancer.
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ABSTRACT 
Growth is a fundamental aspect of life cycle of all organisms. Development of 
multicellular organisms requires generation of an individual with optimally sized, 
interdependent organs from a single cell. Body size varies highly in most animal 
groups, such as mammals. Moreover, growth of a multicellular organism is not 
uniform enlargement of size, but different body parts and organs grow to their 
characteristic sizes at different times. Currently very little is known about the 
molecular mechanisms governing this organ-specific growth.   
The genome sequencing projects have provided complete genomic DNA sequences 
of several species over the past decade. The amount of genomic sequence 
information, including sequence variants within species, is constantly increasing. 
Based on the universal genetic code, we can make sense of this sequence 
information as far as it codes proteins. However, less is known about the molecular 
mechanisms that control expression of genes and about the variations in gene 
expression that underlie many pathological states in humans. This is caused in part 
by lack of information about the second genetic code that consists of the binding 
specificities of transcription factors and the combinatorial code by which 
transcription factor binding sites are assembled to form tissue-specific and/or ligand-
regulated enhancer elements.  
Our hypothesis is that growth in vivo is controlled by direct integration of ligand-
regulated and tissue-specific transcription factor signals on enhancer elements of 
critical growth regulatory genes, such as the Myc genes. 
This thesis presents a high-throughput assay for determining transcription factor 
binding specificities, which was then used to measure the DNA-binding profiles of 
transcription factors involved in growth control. We developed ‘enhancer element 
locator’, a computational tool, which can be used to predict functional enhancer 
elements. A genome-wide prediction of human and mouse enhancer elements 
generated a large database of enhancer elements. This database can be used to 
identify target genes of signaling pathways and to predict activated transcription 
factors based on changes in gene expression. Predictions validated in transgenic 
 mouse embryos revealed the presence of multiple tissue-specific enhancers in mouse 
c- and N-Myc genes, which has implications on organ specific growth control and 
tumor type specificity of oncogenes. Furthermore, we were able to locate a variation 
in a single nucleotide that carries a susceptibility to colorectal cancer to an enhancer 
element and propose a mechanism by which this single-nucleotide polymorphism 
might be involved in generation of colorectal cancer.  
 
 
Keywords: organ-specific growth control, transcription factor, enhancer element, c-
Myc, N-Myc, regulatory SNP  
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TIIVISTELMÄ 
Kasvu on olennainen osa kaikkien eliöiden elinkaarta. Kaikki eläimet kasvavat, 
mutta niiden koko vaihtelee lajien välillä huomattavasti useimmissa eläinryhmissä, 
kuten esimerkiksi nisäkkäissä. Hedelmöittyneen munasolun kehittyessä 
monisoluiseksi yksilöksi kasvavat elimet oikeaan kokoonsa. On huomionarvoista, 
että monisoluisten eliöiden kasvaessa niiden koko ei suurene tasaisesti, vaan eri 
ruumiinosat ja elimet kasvavat lajityypillisen kokoisiksi kehityksen eri vaiheissa. 
Tällä hetkellä tiedetään hyvin vähän molekyylitason mekanismeista, jotka säätelevät 
elinkohtaista kasvua. 
Viimeisen kymmenen vuoden aikana on sekvensoitu useiden lajien genomit. 
Genominlaajuisen sekvenssitiedon määrä kasvaa jatkuvasti, ja se sisältää tietoa 
myös lajien sisäisistä sekvenssivariaatioista. Universaalin geneettisen koodin 
perusteella pystymme lukemaan ja ymmärtämään saatavilla olevaa DNA-
sekvenssitietoa niiltä osin kuin se koodaa proteiineja. Huomattavasti vähemmän 
tiedetään mekanismeista, jotka ohjaavat geenien luentaa DNA:sta RNA:ksi ja 
sairauksia aiheuttavista säätelyn variaatioista. Tämä johtuu osaltaan siitä, että 
tiedämme hyvin vähän niin kutsutusta ”toisesta geneettisestä koodista”.  Toinen 
geneettinen koodi koostuu transkriptiotekijöiden tunnistesekvensseistä ja 
yhdistelmäkoodista, jonka mukaan transkriptiotekijöiden sitoutumispaikat 
muodostavat tehostajajaksoja, jotka säätelevät geeniluentaa. 
Hypoteesimme on, että monisoluisen eliön kasvua säätelevät yhdessä kudoskohtaiset 
ja signaalireittien aktivoimat transkriptiotekijät. Näiden transkriptiotekijöiden 
välittämät aktivoivat ja inhiboivat viestit yhdistyvät transkriptiotekijöiden 
sitoutuessa tärkeiden kasvua säätelevien geenien, kuten Myc-geenien, 
tehostajajaksoihin.   
Väitöskirjan tuloksissa kuvataan ensin tehoseulontamenetelmä transkriptiotekijöiden 
sitoutumisspesifisyyden mittaamiseen. Tätä menetelmää käyttäen määritettiin DNA- 
sitoutumisprofiilit useille kasvun säätelyssä keskeisille transkriptiotekijöille. 
Kehitimme myös tietokoneohjelman (enhancer element locator) tehostajajaksojen 
etsimiseen genomisesta DNA-sekvenssistä. Teimme genominlaajuisen ennusteen 
hiiren ja ihmisen tehostajajaksoista. Ennusteen tulokset koottiin tietokantaan, jota 
 voidaan käyttää signaalireittien kohdegeenien tunnistamiseen ja aktivoituneiden 
transkriptiotekijöiden ennustamiseen geenien ilmenemismuutosten perusteella. 
Kokeet muuntogeenisissä hiirissä osoittivat, että  löysimme c-Myc ja N-Myc –
geenien alueelta useita tehostajajaksoja, jotka ohjaavat geenien ilmenemisen tiettyyn 
kudokseen. Tulokset auttavat selittämään elinkohtaista kasvunsäätelyä ja 
onkogeenien kasvainspesifisyyttä. Lisäksi määritimme, että ihmisen paksunsuolen 
syöpään altistava yhden nukleotidin variaatio sijaitsee tehostajajaksossa ja esitimme 
mekanismin, jolla tämä yhden nukleotidin muutos voi vaikuttaa syövän syntyyn. 
 
Avainsanat: kasvun elinkohtainen säätely, transkriptiotekijä, geenin 
säätelyelementti, c-Myc, N-Myc, säätely-SNP 
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ABBREVIATIONS 
 
Akt v-akt murine thymoma viral oncogene 
homolog 
Apc  adematous polyposis coli 
BAC  bacterial artificial chromosome 
bp  base pair   
3C  chromosome conformation capture 
Cdk  cyclin-dependent kinase 
CGNP  cerebellar granule neuron precursor 
ChIP  chromatin immunoprecipitation 
ChIP-chip chromatin immunoprecipitation followed 
by DNA microarray 
ChIP-seq chromatin immunoprecipitation followed 
by parallel sequencing 
CM cis-module 
c-myc, MYC v-myc myelocytomatosis viral oncogene 
homolog (avian) 
Ds Dachsous 
dPTEN Drosophila phosphatase and tensin 
homolog 
E  embryonic day 
E box   enhancer box element 
EEL  enhancer element locator 
E2F  E2F transcription factor 
Ets-1  erythroblast transformation specific or  
E twenty-six (avian erythroblastosis virus 
E26)  
11 
Ft  Fat 
GFP  green fluorescent protein 
GLI  glioma-associated oncogene 
Hh  Hedgehog 
HOX  homeobox 
HUGO  The Human Genome Organization 
IGF  insulin-like growth factor 
kb  kilobase pair 
lacZ  beta galactosidase reporter gene 
L-myc, MYCL v-myc myelocytomatosis viral oncogene 
homolog, lung derived (avian) 
Max  MYC associated factor X 
Mb mega base pair 
mRNA messenger ribonucleic acid 
N-myc, MYCN v-myc myelocytomatosis viral related 
oncogene, neuroblastoma derived (avian) 
p27
Kip1
, CDKN1B 27 kDa cdk inhibitory protein, cyclin-
dependant kinase inhibitor 1B  
p190-B Rho-GAP, ArhGap5 Rho GTPase activating protein, Rho 
GTPase activating protein 5  
PBM  protein binding microarray 
PCR  polymerase chain reaction  
PI3K  phosphaditylinositol 3-kinase 
PN  postnatal day 
pRB  retinoblastoma protein  
SAGE  serial analysis of gene expression 
SELEX systematic evolution of ligands by 
exponential enrichment 
Shh sonic hedgehog 
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SNP  single-nucleotide polymorphism 
S6k  ribosomal protein S6 kinase 
Tcf4, TCF7L2   T-cell-specific transcription factor 4,  
  transcription factor 7 -like 2 
TFII general transcription factor for RNA 
polymerase II 
TGF!  transforming growth factor beta 
TOR  target of rapamycin 
Wnt wingless-type mouse mammary tumor 
integration site family 
YAC  yeast artificial chromosome  
YAP1  yes-associated protein 1 
 
 
Where two abbreviations are given, the former is commonly used name and 
the latter is the name approved by the Human Genome Organization 
(HUGO). 
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1 INTRODUCTION 
Growth is one of the hallmarks of life. It is fundamental to all biological 
systems. Animals grow to distinctive sizes; their bodies and organs develop 
well-proportioned in a harmonious fashion. Giraffes have tall necks, 
elephants have long trunks, and never vice versa. Our arms grow to the 
same length and internal organs fit neatly into the body cavity. Abundant 
research has focused on defects and disarray of growth, namely cancer. But 
how is growth regulated when it is happening under normal circumstances, 
in an intact organism? How do we grow to be a certain size?  
Animals reach characteristic sizes during fetal period and early life. Fish 
may continue to grow throughout life but most animals, like mammals and 
birds, cease to grow after reaching a certain size. Moreover, growth of a 
multicellular organism is not uniform enlargement of size, but various 
organs and body parts grow to their characteristic sizes at different times. 
Growth is a very basic aspect of development, yet physiological 
mechanisms that control growth remain poorly understood both at the level 
of animal and organ size (Conlon and Raff, 1999). 
Based on the universal genetic code by which DNA encodes amino acids, 
we can make sense of the DNA sequence data as far as it encodes proteins 
(Crick, 1966; Nirenberg, 1963). Genomes of many species have been 
sequenced, including man (Lander et al., 2001; Venter et al., 2001), mouse 
(Waterston et al., 2002), and fruitfly (Adams et al., 2000), and the amount 
of genomic sequence data available is constantly increasing. The universal 
genetic code has allowed researchers to find new genes and estimate the 
total number of genes in the genomes. However, protein-coding sequence 
covers only a few percent of mammalian genomes. New codes and 
grammatical rules need to be resolved in order to understand the remaining 
genomic sequence. It is evident that genes are expressed in tightly 
controlled spatial and temporal patterns, but we do not know the code by 
which the expression is regulated. In this post-genomic era, the next big 
goal is to decipher the genetic code of regulation of gene expression. 
Regulation of gene expression provides a potential, but currently 
unexplored, means of size control. This thesis will discuss size control and 
regulation of gene expression in mammals. The focus will be on molecular 
mechanisms of size regulation, with a special interest in organ size. 
However, as a lot of the research relating to size has come from animals 
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other than mammals, examples of those will also be mentioned where 
appropriate. Discussion on regulation of mammalian gene expression will 
bring enhancer elements into the spotlight.  
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2 REVIEW OF THE LITERATURE 
2.1 Animal size 
The largest mammal, and at the same time the largest animal ever lived, is 
believed to be the blue whale (Balaenoptera musculus). Its maximum-
recorded weight is 190 tons, while the smallest bats and shrews weigh 
about 1.5 g. More than 100,000,000 Etruscan Shrews (Suncus etruscus),  
one of the smallest mammals today, are needed to balance the scale with 
one blue whale. The largest land-dwelling animal at present, the African 
bush elephant (Loxodonta africana), weighs as much as 3,000,000 shrews. 
Despite the difference in size, these organisms have the same overall body 
plan and the same organs, functioning in similar manner. Elephants and 
shrews had a common ancestor about 70 million years ago. Even though 
their genome projects are only on the way, they probably have highly 
similar coding sequences. In the mammalian genomes, there is 
extraordinary capacity to regulate size. 
In addition to the observed size variation across species, animals within a 
single species hold a huge potential for size differences. Even though, in 
their natural environment, individuals of a single species seem relatively 
similar in size, application of artificial selection pressure for size reveals an 
ample genetic potential behind the uniform appearance. Various long-term 
breeding experiments and animal husbandry have produced size phenotypes 
in experimental and domestic animals. This has prepared the way for 
identification of the underlying genetic determinants. In an interesting 
study, chicken from a single founder population were bred and selected for 
size for 45 generations. This selection resulted in two lines of chicken 
showing 9-fold difference in size. Quantitative trait locus analysis revealed 
13 loci affecting growth (Jacobsson et al., 2005). This result reflects the fact 
that body size is a classic example of a complex trait where multiple genes, 
as well as environmental factors, influence the final outcome. Growth rate 
and body size have also been studied in laboratory mice (Allan et al., 2005; 
Cheverud et al., 1996; Kenney-Hunt et al., 2006; Morris et al., 1999). These 
studies, similarly to the chicken experiments, show that it is very 
challenging to create a line of mammals or birds that is selected purely for 
size. Selection for size results in additional traits influencing level of energy 
intake, efficiency of energy conservation, fat deposition, appetite, 
reproductive capacity, physical activity, and so on. On one hand, feeding of 
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the high-weight chicken had to be restricted after selection age to avoid 
severe metabolic disorders. On the other hand, significant portion of the 
low weight chicken died of anorexia or never reached sexual maturity. 
These extreme cases highlight the importance of nutrition to growth and 
size (Jacobsson et al., 2005). Availability of food is a very significant factor 
influencing size of an animal. Even though the interest of this review is 
genetic control of growth, not environmental factors, the size-selected 
chicken show how interwoven the nutrition is also in genetic aspects of 
growth control. 
The studies in mice and chicken have provided a large number of 
quantitative trait loci, which are linked to increase or decrease in body size 
and organ size (Kenney-Hunt et al., 2006; Park et al., 2006). However, the 
loci have been too numerous and the coverage of genetic markers has been 
too low to directly indicate candidate genes or other variants for further 
testing.  
Well-documented regulators of overall size are growth hormone and its 
maybe most important downstream effector, the insulin-like growth factor 
(IGF) family of hormones. Deficiency or excess of these hormones results 
in perturbations of systemic growth, examples ranging from man to mouse 
and fly (e.g. Woods et al., 1996). The insulin-signal transduction pathway 
regulates several aspects of cellular physiology, including cellular growth, 
and uptake and utilization of glucose. There are good reasons to couple 
nutritional status with growth, as growth should occur in the presence of 
energy, and small size is more advantageous in the absence of resources. 
The spectrum of dog breeds comprises a special case: one single species 
with enormous size variation. Dogs have been under man-made selection 
pressures for several thousands of years. The smallest and biggest dogs 
today may have 100 times difference in mass. Genetic information from 
individuals of different dog breeds was successfully used to locate a single 
insulin-like growth factor 1 single nucleotide polymorphism (SNP) 
haplotype, which is common in small breeds and nearly absent in giant dog 
breeds (Sutter et al., 2007). Sutter and colleagues were not able to identify 
the causative variant. They found only one variation in the coding 
sequence, a synonymous SNP. However, they found numerous of small-
breed-specific SNPs and other variations in introns and flanking genomic 
sequence (Sutter et al., 2007). Further studies will resolve the causative 
variant, good candidates being regulatory elements, which will be discussed 
in detail later. 
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2.2 Growth 
Different sizes of animals are produced by differences in growth. Growth 
can be achieved by cell growth (increase in cell size), by increased rate of 
cell proliferation, by decreased rate of cell death, and by increase of 
extracellular space (accretionary growth) (Figure 1). In this study growth by 
increase of extracellular space will not be discussed.  
In multicellular animals, the overall control of growth is crucial. The 
growth and proliferation within an organism, body parts, organs and 
individual cells has to happen in concert. Extracellular signals are important 
in this global control of growth. Growth factors stimulate cell growth. 
Mitogens stimulate cell division. Survival factors suppress cell death. Some 
factors may transmit combinations of these signals simultaneously. A single 
factor may function as a growth factor and a mitogen, for example. 
 
 
Figure 1. Growth can be regulated by change in cell size, in cell 
number, in rate of apoptosis, or in amount of extracellular matrix.  
2.2.1 Cell size 
Different aspects of growth are interdependent. However, cell growth, 
meaning enlargement of cells, is the first requirement for growth of an 
organism or organ. Proliferation, or division of cells, alone will never 
increase overall size, but just divide the existing mass into smaller and 
smaller units, the very phenomenon which takes place in cell divisions of 
mammalian morula.  
Most mammalian cell types in vivo are of similar size in different species 
irrespective of the animal size; compared to a shrew, an elephant has more 
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of the same sized cells rather than bigger cells (Gregory, 2004; Stone et al., 
1992). Yeast cells have a cell-size checkpoint, a mechanism that monitors 
cell size and allows cell division only after certain size is achieved (Fantes 
and Nurse, 1977). The size checkpoint is adaptable, however, as the size is 
dependent on specific culture conditions. There is an ongoing dispute over 
the existence of such size checkpoint in mammalian cells (Cooper, 2004; 
Echave et al., 2007). Definitely some specialized mammalian cells, such as 
neurons and muscle cells, can become very large and the size is species-
specific (e.g. big animals have very long axons in their neurons). It is 
possible that different cell types in mammals have different control systems 
for size. 
Increase in cell size may increase the size of an organism in flies. Mutations 
in the insulin/IGF pathway cause alters size of the fly mainly by altering 
growth (reviewed in Potter and Xu, 2001). Drosophila melanogaster fruit 
flies with a mutation in the Drosophila phosphatase and tensin homolog 
(dPTEN) gene are larger than normal due to bigger cell size. Conversely, 
inactivation of the ribosomal protein S6 kinase (S6k) gene in Drosophila 
results in smaller cells, and thus smaller fly overall. Members of the 
insulin/IGF family of ligands and receptors have been knocked out also in 
mice. As expected, deficiency of these proteins results in various degrees of 
size reduction, as well as other abnormalities (Rother and Accili, 2000). 
The insulin-like growth factor signaling is mediated downstream by 
phosphoinositide 3-kinase (PI3K), Akt and/or TOR pathway (Figure 2). 
Several members of this pathway give growth related phenotypes when 
knocked out in mouse. The most severe phenotypes are caused by PI3K 
catalytic subunit p110! or p110" deficiency, which lead to embryonic 
lethality at E10.5 and E3.5 respectively (Bi et al., 2002; Bi et al., 1999). 
Akt1 deficient mice are smaller than normal (Chen et al., 2001; Cho et al., 
2001). Loss of S6k reduces mouse weigh by 10% (Dufresne et al., 2001). 
None of these mice was reported to have reduced cell size, even though 
deficiencies of the same pathway altered the cell size in the fly. Also, it was 
not addressed whether these effects could be caused by suboptimal function 
of placenta in the knockout mice. Genes affecting growth may also affect 
growth in the placenta, and a small/underdeveloped placenta may lead to 
smaller offspring.  
Genetic manipulation of PI3K pathway in a specific organ of mouse, the 
heart, results in alteration of cell size as well as organ size (Shioi et al., 
2000). Transgenic mice expressing constitutively active PI3K in the heart 
have larger heart size due to bigger cell size. Mice expressing dominant 
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negative mutants of PI3K have smaller hearts and smaller myocytes. 
Possibly this result relates to the plasticity of cell size of myocytes.  
 
Figure 2. Schematic presentation of the IGF, PI3K, Akt and/or TOR 
pathway. 
 
Mice lacking p190-B Rho-GAP (Rho GTPase activating protein) are 
reported to be about 30% smaller than normal mice and to die immediately 
after birth (Sordella et al., 2002). This is, to the best of my knowledge, the 
only reported case where the reduction in size of a knockout mouse is 
explained by smaller cell size than normal. p190-B Rho-GAP stimulates the 
GTP hydrolysis activity of Rho proteins. These mice also have smaller 
thymus than normal. It is proposed that p190-B Rho-GAP modulates 
IGF
Y
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signaling from insulin/IGFs (Sordella et al., 2002). Why only this 
modulator of insulin/IGFs signaling would affect cell size and not the other 
components of the same pathway remains an open question. 
As variation in cell size is fairly restricted in mammals, the cell number 
plays an important role in determining the final size. Cell number is 
principally affected by proliferation.  
2.2.2 Proliferation 
The cell division cycle, usually called the cell cycle, is the fundamental 
means by which all living cells propagate. It is of fundamental importance 
that the daughter cells receive identical, faithfully replicated chromosomes 
and all necessary cytoplasmic organelles. Therefore an elaborate control 
system is needed to coordinate the cycle as a whole. In multicellular 
organisms, in comparison to unicellular organisms, the control of cell cycle 
is even more vital as the cell proliferation has to be balanced within 
different cell types, tissues and organs of the organism. The cell cycle 
progression, as well as the cell size, of animal cells are controlled by signals 
from other cells (Conlon and Raff, 2003). 
The progression of the cell cycle is thought to be dependent on the 
sequential activation of cyclin-dependent kinases (cdks), which depend on 
cyclin subunits for their activity. Oscillations in the synthesis and 
degradation of cyclins control the progressive steps of the cell cycle.  
Studies in yeast have identified Cdk4, Cdk6, pRB, the E2F family of 
transcription factors, Cdk2, cyclin D and cyclin E as critical regulators for 
cell cycle (Nurse, 1991). 
Surprisingly, many of the cell cycle genes are largely dispensable for 
growth of a mouse. Mammalian cdks and cyclins, which were originally 
thought to be consequential for cell cycle, have one by one been shown 
replaceable in mouse development. Mice lacking Cdk4 (Rane et al., 2002; 
Tsutsui et al., 1999), Cdk6 (Malumbres et al., 2004), or Cdk2 (Berthet et 
al., 2003; Ortega et al., 2003) are viable. Moreover mouse lacking all 
interphase cdks, Cdk2, Cdk3, Cdk4 and Cdk6, develops till midgestation 
(Santamaria et al., 2007). Interestingly, genetic substitution of Cdk1 by 
Cdk2 causes embryonic lethality before E3.5 (Satyanarayana et al., 2008). 
Therefore, Cdk1 is necessary and sufficient for development of mouse 
embryos until E12.5. Only deficiency of the cyclins A2 and B1, which 
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activate Cdk1, cause very early embryonic lethality (Brandeis et al., 1998; 
Murphy et al., 1997).  
Several other components of the cell cycle machinery have also been 
implicated to be critical in regulation of proliferation. Mice lacking cyclin 
dependent kinase inhibitor p27
Kip1
 were reported to grow bigger than wild-
type mice with an disproportionate enlargement of thymus, pituitary and 
adrenal glands, and gonads (Kiyokawa et al., 1996; Nakayama et al., 1996). 
Simultaneous targeted disruption of transcription factors E2F1, E2F2 and 
E2F3 in mice results in death before E9.5 (Wu et al., 2001). However, it is 
impossible to say to what extent these effects in cell cycle regulator 
deficient mice could result from placental effects. The lack of a protein may 
cause suboptimal growth in placenta and this may hinder the growth and 
development of the fetus. For example retinoblastoma knockout mice were 
originally found to be embryonic lethal at embryonic day 14.5 (E14.5), but 
with a wild-type placenta the mice develop to term (Wu et al., 2003). 
2.2.3 Cell death 
The net outcome in the cell number is a dynamic balance between cell 
proliferation and cell death. If apoptosis, or programmed cell death, is 
increased, the cell number is decreased, and if apoptosis is decreased the 
cell number rises, assuming that the rate of proliferation remains constant in 
a tissue. 
Apoptosis is the suicide program by which cells can kill themselves when 
they are damaged or not needed (Raff, 1992). Activation of apoptosis 
occurs through specific signaling pathways and involves a caspase protease 
cascade. In apoptosis, the cell shrinks and condenses into fragments that are 
phagocytosed by macrophages and neighboring cells.  
Apoptosis is a frequent phenomenon. It is estimated that in an adult human 
being 10 billion cells (0.01% of all cells in human body) die by apoptosis 
every day (Renehan et al., 2001). During development apoptosis is crucial. 
For example in the development of nervous system, the correct number of 
neurons is dependent on survival factors from the target tissue. In an adult 
organism, apoptosis works to maintain the correct size when cells are 
replaced due to damage or dysfunction. Mice lacking key apoptosis signal 
proteins exhibit, for example, brain overgrowth and interdigit webbing 
(Yoshida et al., 1998). 
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2.2.4 Myc genes 
A classic growth regulator is v-myc myelocytomatosis viral ongene 
homolog (avian), or by more familiar name known as c-Myc. c-Myc is a 
well-known proto-oncogene, and its expression is frequently altered in 
human cancers (Pelengaris et al., 2002). The c-Myc protein is a 
transcription factor that forms heterodimers with MYC associated factor X 
(Max) and regulates gene expression of a great number of genes via binding 
its consensus sequence, enhancer box element (E box). Generally c-Myc 
expression is required for proliferation of mammalian cells (Berns et al., 
2000). c-Myc has been suggested to have a role in many growth-related 
aspects including proliferation, cell growth, differentiation and apoptosis. 
The Myc family of transcription factors has four additional members, N-
Myc, L-Myc, S-Myc, and B-Myc. N-Myc and L-Myc are structurally and 
functionally similar to c-Myc, but their expression patterns are partially 
different (Hatton et al., 1996; Stanton et al., 1992). Significantly less is 
known about S-Myc and B-Myc. 
Mice lacking c-Myc were originally reported lethal at E10.5 (Davis et al., 
1993). In 2001, it was reported that, quoting the title of the paper, “c-Myc 
regulates mammalian body size controlling cell number but not cell size” 
(Trumpp et al., 2001). More recent studies have indicated, however, that 
regulation of size in mouse appears to be a placental effect, as c-Myc is 
required for branching morphogenesis of placenta (Dubois et al., 2008). 
Epiblast-restricted c-Myc null embryos with wild-type placenta die later 
than E10.5, but still before E12 (Dubois et al., 2008). The embryos also 
exhibit fetal liver hypoplasia, apoptosis of erythrocyte precursors, and 
functionally defective definitive hematopoietic stem/progenitor cells. 
Members of mammalian Myc gene family, N-Myc and L-Myc may take 
over c-Myc functions. Mice deficient in N-Myc die at E11.5 and have 
defects in multiple organs (Charron et al., 1992; Moens et al., 1992; Stanton 
et al., 1992). Placental rescue of N-Myc deficient mice is presently not 
available. Conditional knockout of N-Myc gene showed that it is essential 
for generation of nervous system (Knoepfler et al., 2002). Mice 
homozygous for a targeted null allele of L-Myc are viable, fertile and 
apparently healthy (Hatton et al., 1996). Conditional targeting of all the 
Myc homologs may be able to dissect the importance of Myc genes in more 
detail. Recent data indicates that Myc genes are involved in regulation of 
organ size, as N-Myc regulates proliferation in mouse retina and 
conditional deletion of N-Myc gene results in reduced retinal size (Martins 
et al., 2008). 
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2.3 Size of organs and body parts 
Diversity of body parts in various shapes and sizes has created the 
multitude of mammalian species around us.  The mechanisms that regulate 
size of mammalian organs and body parts are poorly understood.  
2.3.1 Control of total cell mass rather than cell number 
Several lines of evidence show that mammals, as well as many other 
animals, have mechanisms to control the total cell mass (the composite of 
cell size and cell number). Studies addressing total cell mass have exploited 
the fact that polyploidy increases cell size. For example polyploid 
salamanders, which have bigger cells, grow to the normal size (Conlon and 
Raff, 1999). The number of cells is reduced to compensate for increase in 
cell size, thus maintaining the normal size overall. There are numerous 
Drosophila mutants in which changes in proliferation lead to changes in 
cell size and maintenance of normal cell mass (Potter and Xu, 2001). 
Mammals are more sensitive to developmental perturbations than 
amphibians or insects, as tetraploid mice do not develop beyond E14.5. 
However, at that stage tetraploid mouse embryos contain about half of the 
normal cell number thus maintaining approximately the normal cell mass 
(Henery et al., 1992). Similarly, addition or reduction of cells into/from 
mouse morula does not change the final size of the mouse.  
The same phenomenon, control of the total cell mass, has been observed at 
the organ level in several transplantation and partial organ excision 
experiments. If several fetal spleens are transplanted into a developing 
mouse, they will grow to reach the mass of one normal spleen (Metcalf, 
Transplantation, 1964). Following partial hepatectomy, liver cells 
proliferate to recover the original cell mass (Fausto et al., 2006). These 
observations show that size can be monitored and regulated in organ-
specific manner, but presently many aspects of molecular mechanisms to 
assess and maintain total cell mass are unknown.  
Processes to maintain the normal size include ‘competition’ and 
‘compensation’. These have been studied particularly by in Drosophila 
imaginal discs, where the faster-growing cells outcompete the slower-
growing or missing cells (Nijhout and Emlen, 1998). Fly cells of an organ 
also compensate their size to correct an excessive of deficient number of 
cells. Competition has been proposed to function also in mammals (Oliver 
et al., 2004). 
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2.3.2 Tissue-specific growth factors 
A conceptually simple mechanism to facilitate organ-specific growth is the 
use of tissue-specific growth factors, which would stimulate or inhibit 
growth in specific target tissue. Myostatin, a transforming growth factor ! 
(TGF!) family member, inhibits the proliferation of myoblasts that fuse to 
form skeletal muscle cells. Deletion of myostatin gene in mice makes the 
muscles grow larger than normal (McPherron et al., 1997). Two breeds of 
cattle, bred for beef production, also have mutations in myostatin gene 
(McPherron and Lee, 1997). 
2.3.3 Regulative versus autonomous growth 
Even though our understanding of organ size determination is limited, some 
themes have arisen from the present knowledge. The control of cell growth 
and proliferation within an organ may be autonomous or 
regulative(Stanger, 2008). An organ under autonomous growth control 
maintains the size information and will not change size due to external 
signals or perturbations. In contrast, an organ that grows in regulative 
fashion, obtains signals from outside the organ and the growth is controlled 
at the level of the whole organism. An example of autonomous growth 
regulation is the pancreas: experimental reduction of fetal pancreatic 
progenitor cells results in a smaller pancreas (Stanger et al., 2007). 
Pancreatic progenitor cells, as early as E9.5, are confined to form a limited 
part of the future pancreas. No compensation of pancreatic size occurs after 
ablation of progenitor cells. The information about the organ size is 
contained locally within the cells of the fetal organ, rather than in the 
system of the organ or organism. Conversely, two-thirds of fetal liver could 
be removed in early gestation, and after 4 days its mass was approximately 
back to normal (Stanger et al., 2007). Liver maintains this regenerative 
capacity in adult organism as well. Based on this, there seems to be two 
types of organs. The first type depends on intrinsic signals for growth and 
does not regenerate in fetal life nor adulthood. The second type depends on 
extrinsic signals for growth, does regenerate in adulthood and exhibits 
regulated growth in development. Organs that have the capacity to 
replenish themselves to varying extent throughout adult life are the 
intestine, blood, skin and liver. The kidney, spleen and pancreas are 
examples of organs that do not readily regenerate in full-grown organisms.  
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The above study suggests that the pancreatic size is determined by number 
of progenitor cells. However, it seems that different mechanisms function 
in determining the size of the very same organ. Conditional removal of 
adenomatous polyposis coli (Apc) gene in pancreatic epithelial cells from 
E10.5 onwards causes pancreas to enlarge several fold due to hyperplacia 
of pancreatic exocrine cells (Strom et al., 2007). Conditional inactivation of 
c-myc gene in pancreata lacking Apc completely reversed the hyperplacia 
(Strom et al., 2007). 
2.3.4 Patterning 
Size of body parts is coupled to pattern formation. Patterning is an 
embryologic process that specifies different cell fates spatially and 
temporally in a structure that is initially largely homogenous. Defects in 
patterning result in altered shape, size, or complete omission of the effected 
organs or body parts. On the one hand, if patterning is perturbed, part of a 
structure might be missing and result in reduced size. On the other hand, 
ectopic expression of a signaling molecule may result in pattern 
duplications and excessive growth. A drastic example of perturbed 
patterning was caused by thalidomide, a sedative, which was used in early 
pregnancy and resulted in congenital defects of limbs in thousands of 
children (Knobloch et al., 2007). 
Hox genes, which determine body regions along the anterior-posterior axis, 
are likely to affect size of homologous structures, e.g. vertebrate ribs, 
within an individual. Experimental evidence for this has been found in 
Drosophila, where Hox gene Ultrabithorax limits size of the haltere (small 
appendage used to balance during flight) by restricting transcription and 
mobility of the morphogen Decapentaplegic (Crickmore and Mann, 2006). 
Patterning has been studied particularly in limb development. Recent 
evidence indicates that proliferation and pattern formation may be regulated 
by the same signaling pathways. Alterations in the duration and range of 
signaling may underlie morphological differences in the evolution of 
vertebrate limbs (Yang, 2009).  
2.3.5 The steepness hypothesis of morphogen gradients 
The Hippo signaling pathway has been identified in Drosophila 
melanogaster as an intrinsic mechanism that restricts organ size in 
 28 
development (Edgar, 2006). The Hippo pathway was also found to regulate 
liver size in mice: Overexpression of a constitutively activated Hippo 
pathway target, transcriptional coactivator yes-associated protein 1 (YAP1), 
in mouse liver causes reversible 4-fold increase in liver size (Camargo et 
al., 2007; Dong et al., 2007). The Hippo pathway may serve as the signal to 
stop tissue growth once the correct size has been achieved in liver. A 
mechanistic hypothesis, the steepness hypothesis, has been proposed to link 
morphogen gradients to cell polarity and growth in Drosophila (Lawrence 
et al., 2008). Lawrence and colleagues propose that morphogens, which set 
up the pattern of the organ, determine a linear gradient of protocadherins, 
Fat and Dachsous (Ft and Ds). According to the steepness hypothesis, the 
direction of the Ds/Ft gradient determines the cell polarity within an organ 
and the steepness of the same gradient determines the die-or-divide 
decisions through the Hippo pathway (Lawrence et al., 2008). Even though 
the hypothesis is still incomplete and there are many open questions 
remaining, it is an inspiring framework, because it could explain how the 
information about growth decisions and dimensions of an organ is 
combined to create the correct size. 
Vertebrates have four Ft homologs and two Ds homologs (Rock et al., 
2005). Fat4 has recently been knocked out in mouse (Saburi et al., 2008). 
The Fat4
-/-
 mice die at birth; they have curved body axis and curly tails. 
They have defects in the inner ear, similarly to other vertebrate mutants of 
core planar cell polarity genes. Interestingly, loss of Fat4 disorganizes the 
oriented cell divisions and tubule elongation in kidney development. 
2.4 Overview of regulation of mammalian gene expression 
As coding regions are similar between different metazoan species, it is 
likely that organ and animal size are encoded in the more divergent 
regulatory regions that control gene expression. Even though the 
comprehensive data is not available today, it seems that metazoans, ranging 
from sea squirt to squirrel, have similar numbers of genes coding for 
proteins and RNAs (Ensembl database, www.ensembl.org). There is 
multiple evidence for mutations causing changes in amino acid sequence 
that result in altered physiology or morphology (for example fur color 
Majerus and Mundy, 2003). However, reported changes in protein coding 
sequences resulting in phenotypic alteration are rare relative to the 
extensive diversity of body forms (Carroll, 2005; King and Wilson, 1975). 
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To the best of my knowledge, presently there is no report of change in 
amino acid sequence causing alteration of size between species. Moreover, 
many of the developmental regulators, which affect for example growth, 
are highly conserved across species. A considerable part of the phenotypic 
diversity between metazoan species seems to rise from somewhere other 
than difference in the number of genes or variation in their coding 
sequences. A very good candidate for additional origin of morphological 
diversity is regulation of gene expression.  
Mammalian gene expression is controlled at many levels. The first and 
most general level of control is the chromatin state. The second level of 
control is initiation of transcription. Further levels of controlling gene 
expression include processing of the transcript, transport of messenger 
RNA (mRNA) into cytoplasm, control of translation, degradation of 
mRNA, and ultimately control of protein activity and degradation. It is not 
possible to exhaustively evaluate the relative importance of these different 
levels of control. The most important regulation in eukaryotes has been 
considered to take place at initiation of transcription. Even though evidence 
is increasing for important examples of control at other levels, initiation of 
transcription is still the starting point, without which the regulation at 
further levels could not happen.  
In recent years, the non-coding RNAs have gained much attention. 
MicroRNAs also perform functions regulating transcription following many 
common (and some different) principles as transcription factor-mediated 
gene regulation (Hobert, 2008). They modify existing transcriptional 
programs by channeling mRNAs into degradation. Their importance lies in 
the fine-tuning and pruning the expression patterns rather than generating 
new patterns. In this discussion, I will focus on regulation of gene 
expression at the level of transcriptional initiation by distal enhancer 
elements. 
2.4.1 Chromatin state 
The nucleus is a complex functional unit. Even though it is not divided into 
membrane-bound compartments like cytoplasm, it contains many 
functional sections involved in different aspects of transcription. Genomic 
DNA is distributed into spatially and functionally distinct entities within the 
nucleus. Chromosomes occupy specific nuclear spaces or territories, and 
genetic loci are located in different types of chromatin (Carmo-Fonseca, 
2002). Moreover, the position of a given locus within the nucleus correlates 
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with its expression. Transcriptionally active genes tend to localize to the 
periphery of the nucleus in the ”transcription factories” (Kosak and 
Groudine, 2004). Co-expressed genes co-localize in the same ”factory” 
(Osborne et al., 2004). 
When DNA is highly condensed, it is thought that transcription factors 
cannot access their binding sites, which are packaged around histones and 
in larger chromatin structures. This feature contrasts the two basic types of 
chromatin: euchromatin is transcriptionally active and less condensed, 
while heterochromatin is highly packaged, transcriptionally silent, and 
inaccessible to DNA-binding proteins and chromatin-modifying enzymes. 
Various mechanisms are exploited to control the access of eukaryotic 
transcription factors to the binding sites buried in chromatin. Histone 
modifications, such as methylation, acetylation, ubiquitination, 
phosphorylation, and sumolation of specific recidues, change DNA-histone 
interactions. Modifications in histones are recognized by other proteins and 
may directly influence higher–order chromatin structure. Histone variants, 
which differ from canonical histones mainly in the histone tails, affect 
different stages of transcription. However, it appears that DNA packaged 
around nucleosomes is still to some extent accessible to DNA-binding 
proteins (Li et al., 2007). A prediction model suggests that nucleosome 
density at promoters is also lower than elsewhere in the genome 
(Richmond, 2006).  
Nuclear compartments and chromatin states are often dynamic; chromatin 
can change form and genetic loci may shift between active and silent 
chromatin. However, some chromatin signatures are inherited, resulting in 
epigenetic inheritance. Recent work gives genome-wide evidence that 
histone modifications at promoters are largely invariant in different cell 
types, while enhancers are marked with highly cell-type specific histone 
modification patterns (Heintzman et al., 2009). 
2.4.2 Eukaryotic transcriptional machinery 
The critical player of the eukaryotic transcriptional machinery is RNA 
polymerase II, which transcribes all protein-coding and small nucleolar 
RNA genes, as well as most microRNA and small nuclear RNA genes. In 
distinction from its prokaryotic counterpart, eukaryotic RNA polymerase II 
requires a repertoire of additional protein factors to function. General 
transcription factors for RNA polymerase II (TFIIs), such as TFIIA, TFIIB, 
TFIID, TFIIE, TFIIF, and TFIIH, are involved in the initiation of 
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transcription. RNA polymerase II and the general transcription factors form 
the preinitiation complex and can direct transcription at basal level.  
In multicellular organisms, there is further complexity of transcription 
apparatus compared to unicellular eukaryotes (Levine and Tjian, 2003). 
Tissue-specific TATA binding protein-associated factors (TAFs) of the 
core promoter complex permit selective activation of genes in a particular 
tissue (Freiman et al., 2001). The mediating factors and different 
compositions of core transcription apparatus provide variability in the 
possible assemblies of transcriptional apparatus. Multisubunit cofactor 
complexes (equivalent to the yeast mediator) connect distal activators to the 
core complex and may be induced to undergo conformational changes to 
activate transcription. Cofactor complexes have diversified extensively in 
metazoans (Glass and Rosenfeld, 2000; Malik and Roeder, 2000). 
Diversification of cofactor complexes may reflect the increase in 
complexity of distal transcriptional regulation. Chromatin remodeling and 
modifying complexes assist transcription apparatus to travel through 
chromatin. There is also evidence that these complexes have diversified 
considerably in metazoan and mammalian evolution (Wang et al., 1996). 
More factors of the transcription apparatus may surface with further 
research.  
2.4.3 Regulatory elements of genomic DNA 
Various transcriptional regulatory elements in genomic DNA can be 
subdivided into categories: core promoters, proximal promoter elements, 
enhancer elements, silencers, insulators and global control regions/locus 
control regions (Maston et al., 2006) (Figure 3). 
 
Core promoter 
The core promoter is approximately 30-75 base pairs long docking site for 
the preinitiation complex. It defines the transcription start site and direction 
of transcription. Mammalian promoters may contain various conserved 
sequence elements, the most famous being the TATA box. Mammalian 
promoters can be divided into two classes: conserved TATA box-enriched 
promoters, which initiate transcription at a well-defined site, and more 
plastic, broad and evolvable CpG-rich promoters (Carninci et al., 2006). 
Variability of core promoters has functional significance as composition of 
 32 
the promoter determines its responsiveness to specific activating and 
inactivating signals (Morris et al., 2004; Smale and Kadonaga, 2003). 
 
Figure 3. Transcriptional regulatory elements. 
 
Proximal promoter elements 
The region immediately upstream of the core promoter typically contains a 
lot of transcription factor binding sites. Historically, most regulatory 
sequences have been found within a few kilobase (kb) area upstream from 
the transcription start site. This area, called proximal promoter, can often 
recapitulate some aspects of gene’s expression. The proximal promoter 
contains clustering of transcription factor binding sites. Transcription 
C enhancer element
D silencer
E insulator
F global control region
A core promoter
B proximal promoter
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factors, which bind to the proximal promoter, may provide binding sites for 
activating or suppressing transcription factors of distal enhancer elements 
connecting enhancer to the core promoter (for example Perkins et al., 
1996). 
 
Enhancer elements  
Enhancer elements are genomic DNA sequence elements that have ability 
to regulate transcription irrespective of their orientation in relation to the 
target promoter. Typically enhancer elements specify gene expression 
quantitatively, spatially and temporally to a particular tissue or cell type at 
specific developmental stage. They range in size from hundred base pairs to 
a few kilobases. Enhancer elements may be upstream or downstream 
hundreds of kilobases, or even a megabase, away from the target promoter. 
An enhancer element enforces the regulation from across genes, or an 
enhancer may be located in another gene’s intron (Lettice et al., 2003). 
Also, interchromosomal activation has been suggested in the regulation of 
interferon-! expression in mouse (Spilianakis et al., 2005). 
 
Silencers 
Silencers are composed of binding sites for transcription factors, all or 
some of which have repressor activity. Silencers function in similar way as 
the enhancers; they are “negative enhancer elements”. Repressor function 
of silencers requires recruitment of repressing transcription factors or 
cofactors. Repressor function may take place via blocking a binding site 
from an activating transcription factor, inhibiting the transcription 
apparatus, masking the activation surface of an activator, recruitment of 
chromatin remodeling complexes, or recruitment of histone modifying 
enzymes.  
It was previously thought that eukaryotic transcription is silenced at default 
state, which would make silencers largely gratuitous in the regulation of 
transcription. This view has been challenged by reports of human genome 
being pervasively transcribed (Birney et al., 2007). Silencers do not seem to 
be completely unnecessary in control of eukaryotic transcription, as some 
silencers have indeed been found in eukaryotic genomes. An example of 
disruption of silencer function in humans is fascioscapulohumeral muscular 
dystrophy. The patients have a deletion of a chromosomal repeat, and that 
abolishes a binding site of a repressor complex (Gabellini et al., 2002).  
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Insulators 
Insulators are 0.5-3 kb long sequence elements that limit action of 
transcriptional regulatory elements. Insulators come in two varieties: those 
that block communication between enhancer and promoter when located 
between them, and those that restrict the spread of heterochromatin. In 
vertebrates, there is only one known insulator protein, CTCF (CCCTC- 
binding factor) that binds specific sequence element, blocks enhancer 
activity and also restricts heterochromatin. CTCF was originally discovered 
as a repressor of the chicken c-Myc locus (Lobanenkov et al., 1990). Since 
then CTCF has been found to function in the regulation of several genes 
(Wallace and Felsenfeld, 2007). 
Insulator elements are one of the mechanisms ensuring that the right 
enhancer will interact with the right promoter. The exact mechanism of 
insulator function is still an open question (Bushey et al., 2008). According 
to a prominent model, the loop domain model, insulators form chromatin 
loops and are involved in the nuclear organization of chromatin (Bushey et 
al., 2008).  
 
Global control regions/Locus control regions 
In mammalian genomes a few cases have been found where gene regulatory 
elements act on a number of genes, for example !-globin and Hox gene 
clusters. The regulatory interactions involving many partners may be quite 
complex. There are ‘global enhancers’ that modulate expression of several 
genes (Spitz and Duboule, 2008). ‘Global control regions’, or ‘locus control 
regions’, are composed of groups of regulatory elements that act on 
multiple genes (Spitz et al., 2003). The regulatory regions and their target 
genes form regulatory landscapes on the genomic DNA, which may vary in 
different tissues. 
All the regulatory elements mentioned above are regions of genomic DNA 
sequence that in cellular context can have important effects on 
transcription. These DNA sequences cannot deliver such an effect alone; a 
functional party is needed. Transcription factors bound to the enhancer 
elements exert the effects of promoting, enhancing or silencing of 
transcription. 
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2.5 Transcription factors 
Transcription factors are DNA-binding proteins that regulate transcription. 
Transcription factors are composed of two domains: the DNA-binding 
domain and the activating (or inactivating) domain. The DNA-binding 
domain determines the binding specificity. Transcription factors have 
affinity for short, usually 5-20 base-pair DNA sequences. The binding 
specificity is for degenerate sequences, i.e. only some positions are critical 
and some allow flexibility in base composition. The activating domain 
functions independently of the DNA-binding domain. The fundamental 
activating function of transcription factors is to attract, position and modify 
the general transcription factors, cofactor complex and RNA polymerase II 
to boost initiation of transcription. This can happen either directly via 
protein-protein interactions to the components of the transcription 
machinery, or indirectly via altering the chromatin structure. Alterations of 
chromatin structure involve local modifications by various chromatin 
remodeling complexes, histone chaperones and histone removing enzymes 
(Perillo et al., 2008). 
Transcription factors are divided into families based on their DNA-binding 
domains. There are dozens of families of DNA-binding proteins, and only 
few families are mentioned here. GLI/Ci transcription factors that are 
activated by the Hedgehog (Hh) signaling pathway belong to the zinc finger 
family of transcription factors (Pavletich and Pabo, 1993). Tcf4 is activated 
by the Wnt (wingless-type mouse mammary tumor integration site family) 
pathway and contains the high mobility group box as defining domain (Poy 
et al., 2001). c-Ets1 and other Ets transcription factors belong to a family of 
their own, Ets family (Oikawa and Yamada, 2003). Myc transcription 
factors bind DNA as heterodimers with Max protein. They belong to a large 
family and have basic-helix-loop-helix-leucine zipper domain that 
combines two functions: dimerization and DNA binding (Nair and Burley, 
2003).  
2.5.1 Determining the binding specificity of transcription factors 
A crucial aspect of studying transcriptional regulation via enhancers is the 
binding specificity of transcription factors. Different methods exist for 
determining the DNA-binding affinity of proteins. DNA-binding specificity 
is typically presented as positional weight matrix, which is amenable to 
computerized sequence analysis (Table 1). The quality of positional weight 
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matrices is critical to success in enhancer prediction by large-scale genomic 
sequence analysis. Even small distortions in the weight matrices lead to 
erroneous result due to the inherently degenerate nature of transcription 
factor binding specificities and the megabase scale of DNA sequence 
analyzed.  
 
Table 1. Example of positional weight matrix (transcription factor GLI2). 
 Binding site nucleotide position 
 1 2 3 4 5 6 7 8 9 10 14 
A 0.01 0.76 0.03 0.00 .081 0.00 0.17 0.03 0.96 0.37 0.04 
C 0.00 0.14 0.97 1.00 0.07 1.00 0.82 0.94 0.01 0.48 0.06 
G 0.95 0.11 0.00 0.00 0.02 0.00 0.00 0.00 0.01 0.11 0.84 
T 0.04 0.00 0.00 0.00 0.09 0.00 0.01 0.03 0.02 0.04 0.07 
 
 
There are two basic lines of approach that have been used to generate 
positional weight matrices: 1) analysis of occupied sites in given DNA, and 
2) analysis of affinity of a transcription factor to DNA. Examples of the 
first include DNAse footprinting, coimmunoprecipitation of genomic DNA 
with a transcription factor, and modern techniques of chromatin 
immunoprecipitation followed by sequencing of cloned fragments (Wei et 
al., 2006), genomic microarray (ChIP-chip) (Carroll et al., 2005), or parallel 
sequencing (ChIP-seq) (Robertson et al., 2007). These methods determine 
occupied sites in a specific DNA sample and the sites are aligned to deduce 
binding specificity. Chromatin immunoprecipitation based methods 
generally give about 100-500 bp sequence reads around the binding site and 
require use of motif discovery algorithm to find the binding motif. As these 
methods do not directly measure affinity, they are prone to statistical error, 
when small numbers of binding sites are aligned, as is the case with older 
methods. ChIP-chip and ChIP-seq methods identify such large numbers of 
sequences that the methods circumvent most of the pitfalls of traditional 
alignment-based methods. These experiments still may fail to identify 
significant binding sites, because the studied transcription factor may not 
bind all sites under the specific conditions. Also, ChIP-chip and ChIP-seq 
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techniques may identify binding sequences for associated factors rather 
than the intended transcription factor. The special value of ChIP-chip and 
ChIP-seq methods lies in their ability to provide important data on occupied 
sites in a particular cell line or tissue sample.   
The DNA affinity of a transcription factor can be obtained by binding the 
protein of interest to every permutation of n positions of duplex DNA. The 
output can be read by determining the intensity of binding or sequencing 
sufficient number of bound DNAs. Earlier applications of this idea are 
SELEX (Systemic Evolution of Ligands by Exponential enrichment) and 
SELEX-SAGE (SELEX-Serial Analysis of Gene Expression) -type 
methods, but these techniques are labour-intensive in large scale as they 
include multiple rounds of PCR, cloning and sequencing (Roulet et al., 
2002). High throughput has been achieved using bacterial one-hybrid 
system (Meng et al., 2005; Noyes et al., 2008). However, possible incorrect 
folding of mammalian DNA-binding domains when expressed in E. coli 
will be a limitation of this method. Protein binding microarrays (PBMs) 
utilize binding of labeled protein on microarray containing every 
permutation of up to ten positions of duplex DNA (Badis et al., 2008; 
Berger et al., 2006; Warren et al., 2006; Zhu et al., 2009). These studies 
provide high quality data for in silico identification of binding sites. Despite 
the several methods available, the knowledge of binding specificities is still 
presently lacking for hundreds of mammalian DNA-binding proteins. 
It would be of great value to be able to predict transcription factor binding 
specificity from the amino acid sequence of the protein. Limited success in 
binding specificity prediction is probably caused by large influence of 
secondary and tertiary structure of DNA-binding domain on binding 
specificity and interdependence between positions of the binding site 
further complicating the situation (Benos et al., 2002; Miller and Pabo, 
2001; Wolfe et al., 2001). The best predictions so far are based on existence 
of knowledge on binding specificity of a sufficiently similar homolog or 
ortholog (Berger et al., 2008). 
Besides DNA affinity, there are several variables affecting the functionality 
of transcription factor binding sites in vivo: concentrations of transcription 
factors in the specific cell, secondary interactions with other proteins 
(complex formation) and chromatin environment of the specific cell. It is 
likely that transcription factors, or at least some of them, are in limiting 
concentration in the cell.  
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2.6 Enhancer elements  
What is known about enhancer elements currently, and how have they been 
studied? 
2.6.1 Physical contact between enhancer and promoter 
Regulatory elements in mammalian genomes are widely spread out. Distal 
enhancer elements may be located hundreds of kilobases away from the 
transcription start site. How is the signal from the enhancer element passed 
on to the initiation of transcription? The prevailing model is that DNA 
looping allows the enhancer element and the promoter to interact forming a 
protein complex.  This complex consists of transcription factors binding to 
the enhancer, the transcription machinery and possibly some connecting 
factors (West and Fraser, 2005) (Figure 4).   
Figure 4. Looping model. Protein-protein interactions between the 
enhancer element-bound transcription factors (brown) and general 
transcription factors (blue) stabilize or activate the basal transcription 
machinery to initiate transcription.  
 
It has been challenging to study how the activating signal from an enhancer 
is passed on to the promoter. Microscopy and chromosome conformation 
capture (3C) have provided data to show that DNA looping brings enhancer 
element and its target promoter in close proximity (Dekker et al., 2002). 
Such interactions are, however, transient and overall chromatin state in the 
nucleus is always dynamic and variable. This complicates the interpretation 
of results. Various models have been proposed on how the enhancer and 
promoter come to contact. Passive diffusion and different active processes, 
such as enhancer tracking along the chromatin, movement in actin-
dependent fashion across nucleus and active bending of chromatin, have 
been proposed as possible mechanisms (Dekker, 2008; Perillo et al., 2008).  
RNA pol II
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2.6.2 Combinatorial code of enhancer elements 
An enhancer element is composed of a cluster of transcription factor 
binding sites. The precise order and organization of the sites is probably 
important for enhancer function, but currently limited information exists 
about the rules of enhancer composition. The only principles governing the 
orientation and spacing of transcription factors known today concern a few 
transcription factors which bind DNA as homodimers and heterodimers 
(Remenyi et al., 2004). 
Biological evidence suggests a combinatorial code of transcriptional 
regulation to allow the vast variety of expression patterns observed within a 
single individual and the variety seen across species. Combinations of 
transcription factors could produce a large enough coding potential to 
explain the observed variety in phenotypes. It is estimated that the human 
genome contains about 1400 genetic loci encoding proteins that bind DNA 
in a sequence specific manner (Vaquerizas et al., 2009). As there are about 
30,000 genes in the human genome, and most of them are expressed at 
multiple developmental time points and places, the number of transcription 
factors acting individually is not sufficient to create the coding potential for 
the variety of expression patterns required across the human lifespan. 
Moreover the nearly same proteins as in human being are expressed in 
chimpanzee resulting in considerably different kind of animal. This is 
indirect evidence for existence of combinatorial code by which 
transcription factor binding sites are assembled to form tissue-specific 
enhancers. However, our knowledge of the “grammar” of the code is 
presently very limited. 
2.6.3 Conservation of enhancer elements in different mammalian 
species 
Even though enhancer elements are mainly located in non-coding genomic 
sequence, their sequences are thought to be evolutionary conserved in order 
to maintain their function.  
Mutations are a source of variation. Mutations with greater pleiotrophic 
effects are expected to have more deleterious effects on organism’s fitness 
than mutations with less widespread effects. Enhancer elements can be 
thought to be a more fertile ground for evolution than amino acid coding 
regions, because activity of an enhancer is often restricted to certain tissue 
and time point, therefore it is not pleiotropic. Furthermore, redundancy 
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(which can be achieved by multiple enhancers overlapping in function) and 
compartmentation (enhancers driving expression in specific tissues) 
increase “evolvability”, the capacity to generate tolerable, inheritable 
variation (Gerhart and Kirschner, 2007).  
2.6.4 Genome-wide prediction of enhancer elements 
A plethora of computer programs has been designed for prediction of 
enhancer elements during this millennium alone. They often follow some 
similar, but also varying, principles. Commonly used principles include the 
following: 
1) Conservation of, particularly non-coding, sequence in different species is 
generally considered to imply functional importance. Many programs use 
local or global DNA sequence alignment of two or several species of 
varying evolutionary distance to detect the evolutionary conservation 
(Woolfe et al., 2005).  
2) Regulatory elements are expected to have clustering of binding sites of 
certain affinity. A variety of pattern recognition programs has been used for 
locating binding sites. Binding motifs from different sources, such as the 
Transcfac database (www.biobase.de) or the Jaspar database 
(www.jaspar.cgb.ki.se), or researchers’ own results, are utilized in the 
pattern searching (Knuppel et al., 1994; Sandelin et al., 2004). Some 
programs aim to find several binding sites for a single or few transcription 
factors within one enhancer element (Rajewsky et al., 2002).  
3) Expression profiling experiments potentially identify groups of 
coexpressed genes. Some approaches use such sets of genes to find similar 
motifs, which potentially could be regulatory elements (Kloster et al., 
2005).  
4) Some programs use the assumption that regulatory elements have some 
characteristic properties, which software can be trained to recognize. This 
has given rise to machine learning programs (Kolbe et al., 2004).  
All the above search approaches appear individually and in varying 
combinations in literature. The amount of genomic sequence analyzed in 
various approaches is also highly variable. Many studies have been limited 
to the promoter proximal region (Suzuki et al., 2004). It is typical to search 
for binding sites in the sequences that were found to be homologous by 
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alignment. Another typical variation is to use motif discovery algorithms 
for the aligned sequences.   
An extreme approach for searching regulatory elements has been 
identification of ultraconserved sequences (Woolfe et al., 2005). Four 
elements (ranging in length between 222-731 bp,) which were 100% 
conserved in man, mouse and rat were deleted in mice without observable 
consequences to the mice (Ahituv et al., 2007). Even though conservation is 
considered to reflect functional importance, ultraconservation alone gives 
no hint of the kind of function that the sequence might have. These 
sequences might function as for example replication origins or modulators 
of chromatin structure. Also, we do not know the prevalence of redundancy 
in such elements. The ENCODE project has attempted to locate regulatory 
elements in subset of human genome. They conclude that sequence 
conservation alone is not sufficient to locate regulatory elements (Birney et 
al., 2007; McGaughey et al., 2008). 
2.6.5 Experimental approaches for identifying tissue-specific 
enhancer elements 
Whereas computer software can be used successfully to predict large 
numbers of potential regulatory elements, the experimental validation of 
predictions in large scale is presently challenging. 
 
Transient transgenics in mouse embryos 
Producing transient transgenic mouse embryos carrying the enhancer 
element and a reporter gene (lacZ or GFP) can be used to biologically 
detect the activity of the predicted mammalian enhancer elements. The 
limitations of this procedure include relatively low throughput, only one 
time-point can be analyzed for one mouse litter, possible position effect 
from the random construct insertion site, limitations caused by possible, 
and enhancer-promoter specificity. Furthermore, detection of silencer 
elements would require development of a special experimental system. 
Some problems of mouse transient transgenics could be overcome by use of 
zebra fish or frog embryos with green fluorescent protein to allow 
visualization through development. This is a potential solution assuming 
that the development is sufficiently conserved for the analysis to apply in 
mammals.  
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Large genomic constructs 
Large genomic constructs in bacterial or yeast artificial chromosomes 
(BACs or YACs) can be used to produce transient transgenic mouse 
embryos (Spitz et al., 2003). The gene of interest is tagged with reporter 
gene, and the expression driven from the large construct can be assayed. 
This approach has several advantages. First, reporter gene expression is 
driven by the endogenous promoter. Secondly, the positional effect of the 
insertion site is usually minimal with very large constructs. Third, 
manipulations of large construct (e.g. mutation of binding sites) allow 
identification of also silencers and insulators.   
 
Mutating regulatory elements 
An implicit proof of biological significance of an enhancer element is given 
by its targeted deletion from mouse genome. The examples of this approach 
are relatively few as the technique is time-consuming. Deletion of an 
enhancer element compromised T cell development (Mohrs et al., 2001). 
Dramatically, removal of approximately 1kb enhancer element of Sonic 
Hedgehog (Shh) located about 1 Mb away from its target gene causes 
truncation of mouse limbs (Sagai et al., 2005). In some cases targeted 
deletion of an enhancer element in mouse has not resulted in an apparent 
change in the phenotype (Ahituv et al., 2007). This latter result suggests 
that enhancers are likely to exhibit similar redundancy as protein-encoding 
regions of genes. There are most likely often many enhancers, which ensure 
that critical gene is expressed in the right place. 
Chemical mutagenesis by N-ethyl-N-nitrosourea (ENU) has also been used 
in mice to induce point mutations, which may or may not, have an effect on 
enhancer function (Masuya et al., 2007). Point mutations, which alter 
mouse phenotype, indicate critical transcription factor binding sites in the 
enhancer element. 
 
Chromatin-immunoprecipitation followed by parallel sequencing 
None of the above mentioned methods of biological verification of 
mammalian enhancer elements are easily amenable to high-throughput 
format. A high-throughout approach for enhancer detection was used in a 
recent work. ChIP-seq method against transcriptional coactivator p300 done 
from embryonic limb, forebrain and midbrain ”fished out” enhancer 
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elements of these tissues (Visel et al., 2009). Even though the title of the 
work states that ”ChIP-seq accurately predicts tissue-specific activity of 
enhancer elements”, the enhancer elements were not predicted purely based 
on ChIP-seq data. The authors used also evolutionary conservation for the 
prediction of enhancer elements as they analyzed only elements, which 
were conserved in human and opossum. ChIP-seq is definitely a technique 
that allows genome-scale analysis of binding sites for a DNA-binding 
protein. However, this technique does not confirm that the identified sites 
have enhancer activity, i.e. that they can regulate transcription.  
2.7 Single-nucleotide polymorphisms 
Variations in a single nucleotide are the most common type of sequence 
variants within a species. Over 15 million single-nucleotide polymorphisms 
(SNPs) have been assigned to the human genome according to the Ensembl 
database (www.ensembl.org). SNPs are believed to be responsible for 
majority of the variation seen among individuals in human population. 
2.7.1 Significance of SNPs 
If SNPs are located in functional regions of the genome, they may cause 
variation in a population via different means. SNPs located in coding 
regions may result in functional consequences for example via missense or 
nonsense mutations, alterations in splicing, or mutation in genes coding 
RNAs. However, as majority of the genome is non-coding, many SNPs will 
fall in intergenic regions, and some of them will fall in regulatory elements.  
During past decades, genetic analysis has been highly successful in finding 
disease genes and variants for many single gene disorders. The genetic 
dissection of common polygenic diseases has proven more challenging. The 
biggest value of SNP information is, at the moment, its usefulness in 
constructing haplotype maps that are used to find the genomic locations of 
causative variants for polygenic diseases. The international HapMap project 
has provided data that allows genome-wide association studies to identify 
susceptibility variants for human diseases (Frazer et al., 2007). Genome-
wide association studies provide a means to dissect genetic determinants of 
common, multifactorial diseases. This work has high medical interest 
because common diseases affect large numbers of people.  
Cancer is one example of a disease that can be studied by this approach. 
Common cancers have a genetic component in their etiology, and first 
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degree relatives have usually 2-4-fold risk of developing the same type of 
cancer (Goldgar et al., 1994). Genome-wide association studies have 
identified SNPs with susceptibility for common types of cancers, such as 
melanoma, breast, prostate, colorectal and lung cancer (Easton and Eeles, 
2008). Susceptibility SNPs point genetic locations for targeted screening of 
causative variants. However, the molecular basis behind the associated 
cancer remains unknown for majority of susceptibility SNPs found so far. It 
is expected that the causative change lies somewhere in the vicinity of the 
susceptibility SNP, but its identification is often challenging. 
2.7.2 Regulatory SNPs 
Regulatory SNPs are SNPs that reside in regulatory elements and affect 
gene expression. It is not possible to predict the prevalence of regulatory 
SNPs due to the present lack of knowledge about regulatory elements 
(Hudson, 2003). Most of the identified regulatory SNPs are located in 
proximal promoters or introns, meaning within a few kilobases from the 
transcription start site (De Gobbi et al., 2006; Kim et al., 2009; Mangino et 
al., 2008; Munkhtulga et al., 2007). Some are located in distal enhancer 
elements (Rahimov et al., 2008; Steidl et al., 2007). 
In the future years, our understanding of SNPs and their significance as 
source of variation in a population will certainly increase. Allelic variants 
of SNPs located in enhancers and other regulatory elements provide a 
potential source of variation in location, timing and intensity of gene 
expression. The variation caused by a single SNP might not be drastic, but 
the whole regulatory SNP complement of an individual could importantly 
shape the expression profile through time and space. Such differences in 
expression might explain variation in a multitude of traits, also size of 
organs and body parts, but more applicably susceptibility to diseases. In the 
future, susceptibility SNP analysis from patient’s DNA sample could 
provide risk prediction and for example assessment of need for more 
invasive or expensive cancer screening procedures. Accumulation of 
comprehensive data about regulatory SNPs will take time. Understanding 
the functional relevance of regulatory SNPs will require extensive research 
into the logic of enhancers and other regulatory elements. The work in this 
thesis provides some of the first steps towards that goal.  
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3 AIMS OF THE STUDY 
The motivataion for this work was to address the intriguing phenomenon of 
organ-specific growth. Our hypothesis was that growth in vivo is controlled 
by direct integration of growth factor-activated and tissue-specific signals 
on enhancer elements of critical cell cycle regulatory genes, such as the 
Myc genes (Figure 5). An enhancer element could drive expression of a 
critical growth gene in a specific tissue, and this mechanism could explain 
how specific tissues grow at different times and intensities. 
 
Figure 5. Hypothesis. Different enhancer elements drive expression of the 
target gene in different tissues at specific developmental time points. 
 
The specific aims of this study were: 
1. To determine binding specificities of transcription factors which 
are involved in growth control. 
2. To find evolutionarily conserved enhancer elements, which drive 
expression in an organ-specific manner in the vicinity of genes 
regulating cell cycle progression. 
 
enhancer element
driving expression
in tissue A
enhancer element
driving expression
in tissue B
promoter
Myc
binding sites for growth factor-activated and tissue-specific transcription factors
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4 MATERIALS AND METHODS 
The methods used in the original articles of this thesis are summarised in 
the following table. The number indicates in which publication the method 
has been used (see list of original publications on page 13). 
 
Method  Publication 
Cell culture and transfection I, II, III 
Chromatin immunoprecipitation III 
Collection of samples from cancer patients and controls III 
Electrophoretic mobility shift assay II, III 
Exon array data analysis III 
Generating transgenic mouse embryos and mouse lines II, III 
Histological analysis II 
In silico sequence analysis II, III 
In situ hybridization II, III 
LacZ staining of tissues II, III 
Microarray gene expression experiments III 
Mouse breeding II, III 
PCR genotyping II, III 
Protein-DNA binding assay I, II, III 
RNA extraction and real-time PCR  III 
Recombinant DNA techniques I, II, III 
Recombinant protein production in mammalian cells I, II, III 
SNP array experiments and data analysis III 
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5 RESULTS AND DISCUSSION 
5.1 High-throughput assay for determining specificity and 
affinity of protein-DNA binding interactions 
Lack of knowledge on the binding specificities of transcription factors 
hinders our ability to predict and study transcriptional regulatory elements 
in genomic DNA. This is currently the main obstacle in advancing our 
understanding of code of transcriptional regulation. The binding 
specificities of transcription factors are the basis, the ”letters” of this code. 
Once we know the complete ”alphabet”, it will be much easier to try and 
read the language of transcriptional regulation of gene expression. Binding 
specificity is a crucial aspect of the function of any DNA-binding protein.  
We have developed a method for high-throughput measurement of protein-
DNA binding interactions (I: Figure 1, overview of the method). Briefly, 
the method requires prior knowledge of a high-affinity binding sequence 
(consensus). The DNA-binding protein to be studied is cloned in fusion 
with the Renilla luciferase enzyme. The fusion protein is then incubated 
with double-stranded biotinylated consensus DNA oligonucleotides and 
double-stranded non-biotinylated competitor DNA oligonucleotides. The 
amount of fusion protein that coprecipitates with the biotinylated 
oligonucleotide in a streptavidin-coated microtiter plate is measured by a 
luminometer. If the DNA-binding protein binds to the competitor 
oligonucleotide, the luminescence will be reduced compared to competition 
with a negative control DNA oligonucleotide (e.g. with bases of the binding 
site in a random order). The level of competition measures the affinity of 
DNA-binding protein to the competitor DNA.  
We used this method to determine the binding specificity of several 
transcription factors: GLIs1-3, Ci, Tcf4 and c-Ets1 (II: Figure 1D). The 
results show that the method can be applied for analysis of transcription 
factors from different DNA-binding protein families, including zinc-finger 
(GLI), high-mobility-group (Tcf4) and ETS families (c-Ets1).  
Various methods for determining DNA-binding specificities of 
transcription factors are available (see section 2.5.1 in review of literature). 
The method described here is suitable for high-throughput analysis and 
automation in microwell format. The method measures the inherent affinity 
of a transcription factor to DNA (rather than occupied sites), so it yields 
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high quality weight matrices for location of binding sites in genomic DNA 
sequence by computational analysis. This method is relatively inexpensive 
and does not require very specialized reagents or technology in the 
laboratory. Limitation of our method is the requirement of prior knowledge 
of a high-affinity binding site. However, often some high affinity site is 
known for a transcription factor, or it can be determined, for example by 
ChIP or SELEX. In comparison to microarray technology, the microwell-
based protein-DNA assay described here gives a smaller number (typically 
96 or 385) of more accurate measurements from a larger number of 
samples. However, analysis of every permutation of n base pair binding site 
is more straight-forward in microarray format than by our assay (Badis et 
al., 2008; Berger et al., 2006; Warren et al., 2006; Zhu et al., 2009).  
This assay of specificity and affinity of protein-DNA binding interactions 
can also be used to address other experimental questions besides 
transcription factor binding specificity for DNA. Additional applications for 
this assay include analysis of effects of post-translational modifications, 
mutagenesis, and small-molecule, protein or antibody libraries on protein-
DNA binding.   
5.2 Enhancer Element locator 
Prediction of enhancer elements is challenging because of the size of 
mammalian genomes and the lack of precise knowledge of the ”rules” 
defining enhancer element structure and conservation. Enhancer elements 
are probably a highly variable entity both in size and sequence composition. 
We do know that enhancer elements have transcription factor binding sites 
in them, but the fact that transcription factor binding motifs are short and 
degenerate further complicates the task. Indeed, individual binding sites can 
be found all over genomes, and the majority of them are not functionally 
significant. 
To search for enhancer elements, we have developed a computer program 
called enhancer element locator (EEL), that predicts enhancer elements 
(Palin, 2007; Palin et al., 2006). The enhancer model of EEL is based on 
physical interactions that occur within an enhancer element. EEL searches 
for conservation of enhancer elements in two evolutionarily related species. 
Functionality of an enhancer element is transmitted via the protein complex 
that binds to it. Following this logic, the capacity to bind the same 
arrangement of transcription factors is searched by EEL as indication of 
conservation of an enhancer in two species. Here, ‘arrangement’ means 
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binding sites of specific transcription factors and their distances from each 
other on genomic DNA sequence. Therefore, conservation of arrangement 
does not mean conservation of plain DNA sequence. As input, EEL takes 
two orthologous DNA sequences and positional weight matrices describing 
the binding specificities of a suitable set of transcription factors. EEL 
locates the binding sites in the provided orthologous DNA sequences and 
then aligns the binding sites to look for conserved arrangements of sites. 
EEL gives a score for each predicted enhancer element. The score 
integrates values for three components: affinity, clustering and conservation 
of binding sites (II: Figure 2A). The real occupancy of a transcription factor 
binding site on DNA depends, in addition to the protein’s affinity for DNA, 
on secondary interactions between adjacent transcription factors, as well as 
transcription factors and other proteins in the complex. Currently, there is 
not enough data available to model all the secondary interactions taking 
place in a protein complex on an enhancer element. The most detailed 
structural model of protein complex on an enhancer has been made on the 
interferon-! enhanceosome (Panne et al., 2007). This is a single case where 
the interactions between transcription factors and their contacts to DNA 
have been described in a highly conserved enhancer element. More data is 
needed for more complete understanding of the secondary interactions. In 
the EEL scoring scheme there are two elements, which reflect the possible 
secondary interactions: distance between adjacent binding sites within an 
enhancer (clustering), and conservation of distances between sites in 
orthologous enhancers (II: Figure 2A) (Palin et al., 2006); (Palin, 2007). 
There is evidence that single-nucleotide substitutions, small insertions, and 
small deletions occur freely within regulatory sequences, but that large 
insertions and deletions (>20 base pairs) are statistically almost absent 
within the regulatory sequences, which is consistent with the logic of EEL 
model (Cameron et al., 2005).  
The EEL program was designed to predict mammalian enhancers. 
However, the relative weights of the components (affinity, clustering and 
conservation) are adjustable by changing values for ", µ, # and $ (II: Figure 
2A). Therefore the program can be adapted to search for enhancers, which 
characteristics differ from mammals. As distal enhancer elements may be 
located very far from the coding sequences, it was important that EEL 
program can efficiently analyze long DNA sequences: hundreds of 
kilobases of DNA sequence using dozens of binding motifs are analyzed in 
minutes. The most important characteristic of EEL, in comparison to other 
enhancer prediction methods available, is that it is based on a model of the 
physical interactions within an enhancer element (examples of other 
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enhancer prediction software in section 2.6.4. of review of literature). EEL 
is built to reflect the protein assembly allowing enhancer function and 
ultimately transcriptional regulation of gene expression. Even though our 
knowledge of protein-protein interactions in the process is limited, the EEL 
program can hopefully be developed further in future, as we reach more 
detailed understanding of the mechanisms behind function of enhancer 
elements.    
Limitations of EEL relate to its intrinsic properties. For an enhancer 
element to be located by EEL, the enhancer needs to be composed of a 
conserved clustering of known transcription factor binding sites, which 
binding specificities are known. Should there exist an enhancer element, 
which had very few transcription factor binding sites, or in which the 
binding sites were very sparsely spread out, the chances of finding those 
enhancer elements by EEL are poor. Also, suitable evolutionary distance is 
required between the orthologous sequences analyzed. If the species are too 
closely related, such as mouse and rat, or human and chimpanzee, the 
sequence flanking the transcription factor binding sites has not diversified 
enough reveal the enhancers; the sequence is conserved and EEL predicts 
enhancers everywhere. As binding motifs are short and degenerate, they 
can be found in any sufficiently long DNA sequence, and thus EEL predicts 
enhancers in any conserved sequence, such as coding regions, repetitive 
sequences, and other evolutionarily highly conserved regions (e.g. HOX 
gene cluster in mammals). Therefore, the interpretation of EEL results 
requires understanding of the sequence architecture of the region that is 
analyzed. At the other end of the conservation spectrum, there are 
limitations in finding enhancers in genomic sequence from too distantly 
related species. If the transcription factor binding-sites, or their order, are 
not conserved, it is not possible to locate enhancer elements by EEL. For 
example in Drosophila species, there is considerable variation of binding 
site architecture of regulatory modules even when their function is 
conserved (Simpson and Ayyar, 2008). This might relate to the divergent 
evolution between Drosophila species that are actually more distantly 
related than different mammalian species. 
In general, selection of species, which genomic DNA is analyzed, is very 
important in the prediction of enhancer elements using comparative 
genomic approaches. If a specific trait is studied, the species should have 
phenotypic similarity in that trait. More distantly related species have less 
similarity in enhancer elements. Species are expected to also have non-
conserved enhancers that regulate species-specific patterns of gene 
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expression. Sometimes an enhancer element may be conserved but the 
pattern of gene expression is not. Inclusion of multiple species in the 
analysis generally increases the specificity but decreases the sensitivity in 
the predictions. 
5.3 Genome-wide prediction of mammalian enhancer 
elements 
We performed a genome-wide prediction of enhancer elements by 
analyzing 20,173 orthologous human-mouse gene pairs by EEL (II). The 
analyzed genomic sequence contained coding regions and 100 kb flanking 
sequence in both directions for each gene. The results were stored in a 
relational database, from which data about the binding sites, enhancers, and 
genes could be extracted and further analyzed (II: Figure 3A).  
To validate the genome-wide prediction of enhancer elements, we extracted 
out different sets of data from the relational database, made predictions and 
tested whether they were correct. The approaches used in the validation 
were analysis of overrepresentation of a TF in a similarly expressed set of 
genes (II: Figure 3B, C), in silico prediction target genes of signaling 
pathways (II: Figures 4 and 5), and application of EEL analysis to a 
biological problem of organ-specific growth control (II: Figures 6 and 7).  
The experimental validation of genome-scale enhancer prediction in 
mammals is currently challenging. Tens of thousands of enhancer elements 
are predicted by computational analysis, but the biological validation of 
even a dozen mammalian enhancers in transgenic mouse embryos is 
laborious. Moreover, the experimental validation of regulatory elements is 
always context dependent. Analysis of mammalian embryos requires 
removal of the embryos from the uterus. Therefore only one time-point can 
be studied in one experiment, and a negative result does not rule out the 
possibility, that the element would be functional in a different time point 
and/or cell type. Also, the very same element could have critical function in 
many tissues and stages, or it may act as a silencer in another context. Even 
more time-consuming is validation of enhancer elements by targeted 
deletion in mouse. Possible redundancy of enhancer elements can further 
increase the challenge, so that all the redundant enhancer elements need to 
be targeted before potential phenotype becomes apparent. 
In this work, we obtained a general picture of what a functional mammalian 
enhancer element looks like. It is important to bear in mind, however, that  
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Figure 6. EEL alignment of the enhancer element located in the second 
intron of N-Myc. The enhancer drives expression in the developing tooth. 
Transcription factor binding sites indicated by yellow boxes and respective 
TFs in green. 
GLI Ahr-ARNT
SP1
Smad5 Dof2 Tal1beta-E47S
Irf1
Dof2 Sox9 Elk1
Irf1 HMG-IY
Dof2
Sequence 1: Rattusnorvegicuscomplement
Sequence 2: Homosapiens
 101187 : -agccctccgTGGGTGGTGggctgtttgcgtt-tggTGCGTGgccagcaggcggcgttgt
 102859 : catcc-tcggTGGGTGGTGggctatttgc-tcctggTGCGTGgccagcaggcggcgatat
 101245 : gtctgacgcaagtcaggcagg---gg-atcaaaaagactgggggtgatgggggcACCCCC
 102917 : g-c-gaggccag-caggcgggcccgggatctgaaaggctgggggtggtgggggcACCCTC
 101301 : CCTCca--g-ttcagcagctggcagcaagtgcattagtggttgtgtacgct-tt-ctggg
 102974 : CCTCcctccattcagcagctggctgcaagtgcaacagcagttgtgtacattctcaggggg
 101356 : ag-cctctttccggtttcgat-tg-agtgctgg-tccagttgtgt-ttcctagctggaat
 103034 : cctcctctttccagtgt-gcagtggaaa-ctggctgtagttttgtcttcc-agcctgaat
 101411 : ttctgacctaatt-gag-tg-gagttgtgttccataacccagtgcccttgaggttgaggg
 103091 : tccaggcctaatttgagatgtgagttgtat-ctgtaacccagtgcccttgaaggtgaggg
 101468 : cgggtccct-accactgcccctccttaggaatgcacacaccctggaaggattcattggtt
 103150 : cagg-cactcagca--gcctctcc--aggaaggctcacatcctgggaggactcactgatt
 101527 : ttattgtaagcttttt-tttccgggccgtccgtggaaag--gaagggttaagaaagggaa
 103205 : ag-ttctattgtgttcattt--gt-ctgt--gtcttaagctgaaggg--aaga--gttaa
 101584 : aaacag-ctttttttttccttgggg-ctgtgaaagtacctaccatattttacccaaatcc
 103255 : aaccaagcctttc----cctgggggtctg-gat-gaac--ag-a-actcaacccaaagag
 101642 : tgtc-tgcccttgtcctt----ca--g--ctgt-aggtctattagaccttggaagctagt
 103305 : tggcattgccttgtccttggagcagggagctgggaccccccttggactttgaaaaccagt
 101692 : gttttcacaacgccaaagaatataaaaagtctgaatttcctcctgggctgaggggggaga
 103365 : gttttcagaatgc-ag-gtggataacaagcctaaatttacttctgggctgaggag--aga
 101752 : tcgttggttctaagactcctgggaggaaacttggtgataagcctgcactttgaaagggct
 103421 : tctttg-----agg-ctcctggaaggaaacttggtgataagcctccagtttgaaacggct
 101812 : ctgtccctttaaTGTCTgtgccttgacAGCTTTctg-t-taggaagcagtttcttCCAAC
 103475 : ctgtccctttaaTGTCTgtgccttgacAGCTTT-tggtga-ggaagcacttccttCCAAC
 101870 : AGCTGTCttcttggctgGAAACCAAAACActggcttaaagggacctacagaccgggagca
 103533 : AGCTGTCttcttggcagAAAACCAAAACAttggcttaaagggacccacagactggaa-ca
 101930 : gcctaacagttcAGCTTTagaagaaa-cctcaCAATTGTTCtgcCTTCCGGTCCtccct-
 103592 : gcctcacatttcGGCTTTagaacaaatcc-caCAATTGTTCagcTTTCCGGTCC-ccttc
 101988 : agattaggtagaagatgtGTTTTGATTTTCATGCTTTTTTTTTTTTtaaactataatttt
 103650 : agatcaagcagaagatatGTTTTGATTTTCATGCTTGTATTTTAAA----caataatttt
 102048 : ct-ctcctagcctggcagtaaaccagga-agtc---a-gaatacacataggatgctacat
 103706 : ctacccc-agcgtggtagtcaatgaggagagaggggaagaatgcgcacatgatgctacac
 102102 : gggtgtgt-gtgggttttttttttt-tggttgttcg-ggc-a-ctgctcccatt-gggat
 103765 : gtttctgttgttgctgttattattggtggct-tt-gaggagagctgctcccatttgggg-
 102156 : gtgtgtagctactgtggactagAGCTTTataattgaga
 103822 : gtttataccaactgtggattatGGCTTTgtcattaaga
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choice of the method, in this case the EEL software, produces its own 
biases. Most notably, EEL is not likely to find enhancer elements, which 
would be very different from what is assumed by the EEL model. 
Nevertheless, the results show that in the genome there seems to be 
thousands of enhancer elements, which approximately fulfill the 
characteristics outlined above. A typical mammalian enhancer element 
based on this work is about 1 kb long and contains about a dozen 
transcription factor binding-sites (example in Figure 6). This work did not 
aim at intensely scrutinizing the borders of enhancer elements. Excluding 
predicted enhancer elements which have alternative causes for sequence 
conservation, such as coding region or repetitive sequence, an high-scoring 
EEL-predicted enhancer has a good potential to be functional. To this end, 
knowledge of signaling pathway that regulates expression of predicted 
target gene improves the odds of finding a biologically relevant enhancer 
element. If certain signal pathway is known to regulate the gene, predicted 
enhancer elements, which contain binding sites for the transcription factor 
that is activated by this pathway and also have a high EEL score, are 
prominent candidates for functional enhancer elements.  
5.4 Tissue-specific enhancers of c-Myc and N-Myc loci may 
drive organ-specific growth 
To address the biological problem of organ-specific growth control, we 
chose to study two Myc genes, c-Myc and N-Myc, in more detail. We 
analyzed 200 kb genomic sequence around coding region of these genes 
and were able to identify several enhancer elements that drive expression of 
a marker gene in a tissue-specific manner (II: Figures 6 and 7).  
Two enhancer elements of the N-Myc locus are particularly interesting in 
the light of data available from the tissues where they are expressed (II: 
Figure 7B, C). Enhancer element or cis-module 7 (CM7), located in the 
second intron, drives expression in the maxillary arch derivatives, including 
the developing tooth bud (II: Figure 7B, E). This enhancer contains, among 
other transcription factor binding sites, one conserved binding site for GLI, 
the transcription factor that is activated by the Hedgehog pathway (Figure 
6). At E12.5 the enhancer drives expression in the dental epithelium, 
coinciding with Shh expression (Bitgood and McMahon, 1995). Shh has 
been reported to act as a mitogen and survival factor in the tooth 
development (Cobourne et al., 2001), and our results suggest that this effect 
is mediated via N-Myc protein. In addition to the signal pathway-activaed 
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transcription factor binding site (GLI), this enhancer contains a dozen other 
sites. Of those, at least Ahr-ARNT, SP1, and Smad5 are expressed in the 
tooth area and represent potential tissue-specific transcription factors of this 
enhancer element (Figure 6) (Aitola and Pelto-Huikko, 2003; Bouwman et 
al., 2000; Murashima-Suginami et al., 2008). 
The second enhancer element of N-Myc, CM5, is located 65 kb downstream 
of the N-Myc transcription start site. It contains a conserved GLI binding 
site. At E 12.5, this enhancer drives expression in the forebrain and in the 
dorsal aspect of the neural tube (II: Figure 7C, F, G). Furthermore, in 
newborn mice at postnatal day 3 (PN3) the expression is driven in the 
cerebellar granule neuron progenitors (CGNPs) of the external granule cell 
layer of the cerebellum (II: Figure 7H). It has been shown in cell culture 
and mouse experiments that N-Myc acts downstream of Shh signaling 
during CGNP proliferation, and that N-Myc is essential downstream 
effector of Shh signaling during cerebellar growth (Hatton et al., 2006; 
Kenney et al., 2003; Oliver et al., 2003).  
Multiple tissue-specific enhancers for a single gene, as presented here for 
N-Myc, provide explanation for the mechanism how growth can be 
controlled in different ways in distinct tissues and organs. Also, we located 
two enhancer elements, which both contain conserved GLI-binding sites 
and are potentially Hh pathway responsive, but drive expression in different 
tissues. It is likely that the activity of the enhancer element is controlled, in 
addition to Hh pathway, by transcription factors which expression is 
restricted to specific tissue(s). 
Methods to further validate the importance of these enhancer elements in 
regulation of N-Myc expression include 3C techniques to show physical 
contact between the enhancer and promoter of N-Myc, and targeted deletion 
of these enhancer elements in mouse to show possible phenotypic effect.   
5.5 Regulatory SNP located in an enhancer element affects 
cancer susceptibility  
The human SNP rs6983267, located in the long arm of chromosome 8, 
carries either T or G allele. The G allele has been identified to be associated 
with an increased susceptibility to colorectal cancer in several genome-wide 
association studies (Haiman et al., 2007; Tomlinson et al., 2007; Zanke et 
al., 2007). The large genomic region carrying the SNP rs6983267 is 
amplified in colorectal cancers (III: Figure 1A, B). We found that the SNP 
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rs6983267 falls in a Tcf4 binding site, which is located in a high EEL-
scoring enhancer element (III: Figure 2A). The G allele the final position of 
the Tcf4 binding site results in 1.6 fold increase in the affinity of this 
binding site compared to a Tcf4 binding site with a T allele in this position 
(III: Figure 2B). In genome-wide ChIP assay, this Tcf4 site gives the 
highest signal within 1 Mb of c-Myc (III: Figure 3D). Tcf4 preferably binds 
to the binding site with the risk-allele G in colorectal cancer cell lines (III: 
Figure 3F, G). In cell culture where the Wnt pathway is active, the enhancer 
containing the risk-allele G drives 1.5-fold higher expression of a marker 
gene than the enhancer with the T allele (III: Figure 2D). In transient 
transgenic mouse embryos, the predicted enhancer element drives 
expression of a marker gene in a pattern that is consistent with regulation 
by Wnt pathway (III: Figure 4). These and other lines of evidence in III 
indicate that predisposition to colorectal cancer linked to the G allele in 
rs6983267 increases Tcf4 binding affinity and thus enhances 
responsiveness to Wnt signaling.  
The gene closest to this enhancer is c-Myc, located 335 kb from the 
enhancer. We propose that c-Myc is the target gene of the enhancer element 
that contains the SNP rs6983267. The distance to the proposed target gene 
is long in comparison to previously published regulatory SNPs in other 
genes, maximum published distance being 16 kb (Steidl et al., 2007). But it 
is well within the range of known functional enhancer elements, as a known 
functional enhancer element of Shh is 1 Mb from its target (Sagai et al., 
2005). Together with the Wnt pathway, c-Myc has an important role in 
colorectal cancer. The Wnt pathway is activated in 90% of colorectal 
cancers, and c-Myc has been indentified as a target of the Wnt pathway 
(Bienz and Clevers, 2000; He et al., 1998). c-Myc expression is required for 
the tumorigenic phenotype resulting from APC loss in mice (Sansom et al., 
2007). Our work provides a plausible mechanistic explanation for the link 
between the risk-allele G in the SNP rs6983267 and colorectal cancer. 
It is challenging to explicitly show a correlation between rs6983267 
genotype and the expression level of c-Myc in vivo. We have attempted to 
show the correlation in Epstein-Barr virus transformed lymhoblastoid cell 
lines of HapMap individuals and in colorectal cancer tumor samples. 
Neither of these is optimal starting materials for the analysis. The function 
of enhancer elements is tissue-specific; it is likely that the intestinal 
enhancer element is not functional in other tissues. There is indeed 
evidence that Wnt pathway is not active in Epstein-Barr virus transformed 
lymhoblastoid cell lines (Everly et al., 2004). Colorectal tumors are better 
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starting material in the sense that they originate from the tissue where the 
enhancer is expected to be active. However, colorectal tumors are 
heterogeneous cell populations; they contain various genetic alterations and 
differ in their Wnt signaling status (Fodde and Brabletz, 2007). Therefore, 
the correlation between the rs6983267 genotype and c-Myc expression 
level in tumor tissue may well be perturbed, even if it originally was critical 
in tumor development. Ideally the correlation between rs6983267 genotype 
and the expression level of c-Myc would be analyzed in normal colon. 
However, obtaining sufficient material for RNA extraction from the few 
stem cells at the bottoms of the intestinal crypts, where Wnt signaling is 
active, remains a challenge. One possibility would be to try and show the 
correlation in mice, as obtaining fresh tissue samples from mice is easier.  
The risk allele G is very common in human population, with 50% allele 
frequency in Caucasians and almost 100% frequency in people of African 
origin (Haiman et al., 2007). In fact, the G allele is most likely the ancestral 
form. Consistent with high prevalence of the risk allele, African Americans 
are more likely to develop colorectal cancer and die of it than Caucasians in 
the United States (Polite et al., 2006). Even though there could be 
environmental reasons to account for this, the younger age at presentation 
and the high mortality rates among the younger cohorts of African 
American patients suggest a genetic difference between the two groups 
(Polite et al., 2006).  
All the cancer susceptibility loci found in genome-wide association studies 
confer a relatively low risk of cancer, less than 1.5-fold (Haiman et al., 
2007). Homozygosity for the G allele of SNP rs6983267 increases 
colorectal cancer risk !1.5 fold. It is considered unlikely that loci with 
stronger effects will be found in the future, considering the extensive size 
and the coverage of the genome-wide association studies conducted so far 
(Easton and Eeles, 2008). Likely, this is the nature of susceptibility loci for 
common, low-penetrance, multifactorial diseases. Susceptibility loci will be 
numerous and the effect of each is expected to be minor. Within the 
population the diseases are common compared to single gene disorders, for 
example 5% of population in Western world develops colorectal 
malignancies (Bienz and Clevers, 2000). But the penetrance is low, and the 
prevalence of a risk allele is very high in the population.  
Due to its importance in development of colorectal cancer, the Wnt 
pathway is a self-evident target for rational cancer therapies. Our results 
suggest that the Wnt pathway also has potential as a target for personalized 
cancer prevention strategies. 
57 
5.6 Tissue-specific enhancers may explain tumor-type 
specificity of oncogenes 
Cancers of specific organs exhibit typical genetic alterations. Where does 
this specificity arise?  
One explanation for this phenomenon is the tissue-type specific regulation 
of Myc genes (or other important oncogenes and tumor suppressor genes). 
The majority of human malignancies express one or more Myc genes 
(Pelengaris et al., 2002). Enhancer elements composed of many 
transcription factor binding-sites integrate signals from ubiquitously 
expressed and tissue-specific transcription factors as well as signaling 
pathway-activated transcription factors. Mutations affecting specific 
signaling pathway could lead to unrestricted growth only in tissues where 
additional factors allow the activation of Myc gene expression via a tissue-
specific enhancer element. This could explain why certain genetic 
alterations cause cancer only in particular tissues or organs. 
In III, we propose an enhancer element, which could transmit tissue-
specificity of a constitutively activated Wnt signaling pathway in causing 
colorectal cancer. Medulloblastoma, the most common childhood 
malignancy of the central nervous system, is dependent on Shh signaling 
via N-Myc for unrestricted proliferation of CGNPs (Zindy et al., 2006). The 
enhancer element CM7, described in II, could be a candidate to pass the 
signal of activated Hh pathway to N-myc in formation of medulloblastoma.  
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6 CONCLUSIONS 
This work embarked to address the phenomenon of organ-specific growth 
control. Our hypothesis was that growth in vivo is controlled by direct 
integration of growth factor-activated and tissue-specific signals on 
enhancer elements of critical cell cycle regulatory genes, such as the Myc 
genes The hypothesis focused the area of interest into transcriptional 
regulation via enhancer elements and how organ-specific growth control 
could function via these elements.   
The first obstacle in this work was that only limited information exists 
about the DNA-binding specificities of even well known transcription 
factors. Therefore, we set out to develop a high-throughput method for 
measuring transcription factor DNA-binding specificities. This method is 
applicable to a range of transcription factors, as it was used to determine 
binding specificities of three different families of DNA-binding proteins: 
zinc finger domain (GLI), HMG box (Tcf4) and ETS domain (Ets-1). This 
high-throughput assay is generally applicable method for addressing 
biological problems related to protein-DNA binding interactions.  
The existing computational resources were not sufficient to efficiently 
locate distal mammalian enhancer elements up to hundreds of kilobases 
away from the coding regions of their target genes. To overcome this 
limitation, we developed EEL, a computational tool by which enhancer 
elements can be predicted. We used this program to analyze several 
vertebrate genomes. We performed a genome-wide prediction of human 
and mouse enhancer elements, which provides a large database for different 
uses. For example, we showed that the genome-wide data is useful in 
identification of Hh and Wnt target genes. It could also be used for 
prediction of target genes of other signaling pathways.  
We found multiple tissue-specific enhancers in mouse c-Myc and N-Myc 
genes, thereby uncovering a potential mechanism by which growth and 
cancer can occur in organ-specific fashion.  
Moreover, we have located a regulatory SNP in a Wnt signaling-responsive 
enhancer element 335 kb upstream of c-Myc. This part of the work 
implicates a mechanistic explanation for the link between this SNP and 
occurrence of colorectal cancer. Genome-wide association studies are 
identifying increasing number of SNPs associated with common diseases, 
but usually the causative mechanism remains obscure. This work provides 
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an examle on how common, low-penetrance disease SNP variant could 
transmit the susceptibility to diseases, such as cancer.   
The future work in this project will involve generating mice with targeted 
conditional deletion of the tissue-specific enhancer elements of N-Myc 
gene, which drive expression in the tooth and cerebellum, and the enhancer 
element of c-Myc, which drives the Wnt-responsive expression pattern and 
contains the SNP rs6983267 associated with colorectal cancer. Deletion of 
an enhancer element in mouse will provide an organism level evidence of 
its significance in growth of the respective organs. As the enhancer element 
could be functional in multiple tissues and developmental stages, the 
targeting is best done conditionally. Thus we can delete the enhancer in a 
specific tissue and study the effect there.  
It is clear that not all the regulatory elements of the c-Myc and N-Myc genes 
have yet been discovered. Future work will uncover more enhancer 
elements and reveal more complete picture of the transcriptional regulation 
of c-Myc and N-Myc. 
Even though the Myc genes are critical to growth in many situations, there 
are also other genes which transcriptional regulation would be interesting to 
study in respect to organ-specific growth control. After the beginning of 
this thesis work, cdk1 and cyclins A2 and B1 have been shown to be very 
critical to growth in vivo, as their deletion results in very early embryonic 
lethality (unlike other cdks and cyclins). It could be interesting to 
investigate the enhancer elements of these genes. Also multiple lines of 
evidence have emerged indicating that the IGF genes are critical to growth 
control. Dissection of their regulatory elements could reveal a very 
interesting growth regulatory potential.    
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